Identification of T. gondii epitopes, adjuvants, & host genetic factors that influence protection of mice & humans

Ítems similars

• Towards an immunosense vaccine to prevent toxoplasmosis: Protective Toxoplasma gondii epitopes restricted by HLA-A*0201
  per: Cong, Hua, et al.
  Publicat: (2010)
• Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8(+)T cell epitope based, adjuvanted vaccine protective against Toxoplasma gondii
  per: Cong, Hua, et al.
  Publicat: (2010)
• Toxoplasma gondii HLA-B*0702 restricted GRA7(20–28) peptide with adjuvants and an universal helper T cell epitope elicits CD8(+) T cells producing IFN-γ and reduces parasite burden in HLA-B*0702 mice
  per: Cong, Hua, et al.
  Publicat: (2011)
• Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii
  per: El Bissati, Kamal, et al.
  Publicat: (2016)
• Spiroindolone That Inhibits PfATPase4 Is a Potent, Cidal Inhibitor of Toxoplasma gondii Tachyzoites In Vitro and In Vivo
  per: Zhou, Ying, et al.
  Publicat: (2014)